96 related articles for article (PubMed ID: 24814870)
21. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
[TBL] [Abstract][Full Text] [Related]
22. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia.
Lee SD; Kim W; Jeong JW; Park JW; Kim JE
Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575
[TBL] [Abstract][Full Text] [Related]
23. The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas.
Basyuk E; Coulon V; Le Digarcher A; Coisy-Quivy M; Moles JP; Gandarillas A; Journot L
Mol Cancer Res; 2005 Sep; 3(9):483-92. PubMed ID: 16179495
[TBL] [Abstract][Full Text] [Related]
24. The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes.
Lemos V; de Oliveira RM; Naia L; Szegö É; Ramos E; Pinho S; Magro F; Cavadas C; Rego AC; Costa V; Outeiro TF; Gomes P
Hum Mol Genet; 2017 Nov; 26(21):4105-4117. PubMed ID: 28973648
[TBL] [Abstract][Full Text] [Related]
25. Cripto-1 alters keratinocyte differentiation via blockade of transforming growth factor-beta1 signaling: role in skin carcinogenesis.
Shukla A; Ho Y; Liu X; Ryscavage A; Glick AB
Mol Cancer Res; 2008 Mar; 6(3):509-16. PubMed ID: 18337457
[TBL] [Abstract][Full Text] [Related]
26. Sirt2 epigenetically down-regulates PDGFRα expression and promotes CG4 cell differentiation.
Fang N; Cheng J; Zhang C; Chen K; Zhang C; Hu Z; Bi R; Furber KL; Thangaraj M; Nazarali AJ; Ji S
Cell Cycle; 2019 May; 18(10):1095-1109. PubMed ID: 31020898
[TBL] [Abstract][Full Text] [Related]
27. Sirt2 suppresses inflammatory responses in collagen-induced arthritis.
Lin J; Sun B; Jiang C; Hong H; Zheng Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):897-903. PubMed ID: 24211200
[TBL] [Abstract][Full Text] [Related]
28. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.
Hu L; Crowe DL; Rheinwald JG; Chambon P; Gudas LJ
Cancer Res; 1991 Aug; 51(15):3972-81. PubMed ID: 1713123
[TBL] [Abstract][Full Text] [Related]
29. Crucial Roles for SIRT2 and AMPA Receptor Acetylation in Synaptic Plasticity and Memory.
Wang G; Li S; Gilbert J; Gritton HJ; Wang Z; Li Z; Han X; Selkoe DJ; Man HY
Cell Rep; 2017 Aug; 20(6):1335-1347. PubMed ID: 28793258
[TBL] [Abstract][Full Text] [Related]
30. Alterations in epidermal biochemistry as a consequence of stage-specific genetic changes in skin carcinogenesis.
Yuspa SH; Kilkenny A; Cheng C; Roop D; Hennings H; Kruszewski F; Lee E; Strickland J; Greenhalgh DA
Environ Health Perspect; 1991 Jun; 93():3-10. PubMed ID: 1773799
[TBL] [Abstract][Full Text] [Related]
31. SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation.
Li Z; Huang J; Yuan H; Chen Z; Luo Q; Lu S
Oncotarget; 2016 Apr; 7(14):18927-39. PubMed ID: 26942878
[TBL] [Abstract][Full Text] [Related]
32. Silybin inhibits NLRP3 inflammasome assembly through the NAD
Zhang B; Xu D; She L; Wang Z; Yang N; Sun R; Zhang Y; Yan C; Wei Q; Aa J; Liu B; Wang G; Xie Y
FASEB J; 2018 Feb; 32(2):757-767. PubMed ID: 28970254
[TBL] [Abstract][Full Text] [Related]
33. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation.
Yuan F; Xu ZM; Lu LY; Nie H; Ding J; Ying WH; Tian HL
J Neurochem; 2016 Feb; 136(3):581-93. PubMed ID: 26546505
[TBL] [Abstract][Full Text] [Related]
34. ERK1/2 regulates SIRT2 deacetylase activity.
Choi YH; Kim H; Lee SH; Jin YH; Lee KY
Biochem Biophys Res Commun; 2013 Jul; 437(2):245-9. PubMed ID: 23806683
[TBL] [Abstract][Full Text] [Related]
35. SIRT2 suppresses non-small cell lung cancer growth by targeting JMJD2A.
Xu W; Jiang K; Shen M; Qian Y; Peng Y
Biol Chem; 2015 Aug; 396(8):929-36. PubMed ID: 25719312
[TBL] [Abstract][Full Text] [Related]
36. Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2).
Li J; Flick F; Verheugd P; Carloni P; Lüscher B; Rossetti G
PLoS One; 2015; 10(9):e0139095. PubMed ID: 26407304
[TBL] [Abstract][Full Text] [Related]
37. FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2).
Voelter-Mahlknecht S; Ho AD; Mahlknecht U
Int J Oncol; 2005 Nov; 27(5):1187-96. PubMed ID: 16211212
[TBL] [Abstract][Full Text] [Related]
38. SIRT2 mediated antitumor effects of shikonin on metastatic colorectal cancer.
Zhang LL; Zhan L; Jin YD; Min ZL; Wei C; Wang Q; Chen YJ; Wu QM; Hu XM; Yuan Q
Eur J Pharmacol; 2017 Feb; 797():1-8. PubMed ID: 28088387
[TBL] [Abstract][Full Text] [Related]
39. ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNA.
Zhang H; Head PE; Daddacha W; Park SH; Li X; Pan Y; Madden MZ; Duong DM; Xie M; Yu B; Warren MD; Liu EA; Dhere VR; Li C; Pradilla I; Torres MA; Wang Y; Dynan WS; Doetsch PW; Deng X; Seyfried NT; Gius D; Yu DS
Cell Rep; 2016 Feb; 14(6):1435-1447. PubMed ID: 26854234
[TBL] [Abstract][Full Text] [Related]
40. Sirt2 suppresses glioma cell growth through targeting NF-κB-miR-21 axis.
Li Y; Dai D; Lu Q; Fei M; Li M; Wu X
Biochem Biophys Res Commun; 2013 Nov; 441(3):661-7. PubMed ID: 24161395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
